Medical policies for providers
See the latest updates to our medical policies.
MP197-Janus Kinase 2 (JAK 2) Gene Mutation Analysis
Janus Kinase 2 (JAK 2, JAK 2V617F) mutation analysis has been proposed as a laboratory test to aid in the diagnosis and clinical management of patients with myeloproliferative disorder.
Learn more about Geisinger Health Plan.
Log in to NaviNet to access and view prior authorization information.
Clinical guidelines offer providers consistent and appropriate guidance for diagnosis and treatment of specific conditions or diseases.
Terms and conditions
View GHP’s terms and conditions.
Questions? Contact us
If you have questions or need more information, contact Geisinger Health Plan.